Development of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung Cancer

por He, Jiabei, Hu, Ying, Hu, Mingming, Li, Baolan
Publicado 2015

Prognostic Value of Basic Fibroblast Growth Factor (bFGF) in Lung Cancer: A Systematic Review with Meta-Analysis

por Hu, Mingming, Hu, Ying, He, Jiabei, Li, Baolan
Publicado 2016

The relationship between the preoperative plasma level of HIF-1α and clinic pathological features, prognosis in non-small cell lung cancer

por He, Jiabei, Hu, Ying, Hu, Mingming, Zhang, Siyi, Li, Baolan
Publicado 2016

Survival Analysis of 159 Patients With Advanced Non-Small-Cell Lung Cancer Resistant to First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor

por Hu, Aimin, Li, Kun, Zheng, Hua, Rao, Haitao, Zhang, Tongmei, Li, Baolan
Publicado 2023

Trichomegaly and scalp hair changes following treatment with erlotinib in pulmonary adenocarcinoma patients: A case report and literature review

por Zheng, Hua, Zhang, Hongmei, Zhang, Tongmei, Wang, Qunhui, Hu, Fanbin, Li, Baolan
Publicado 2016

Topoisomerase I expression is associated with prognosis in postoperative non‐small cell lung cancer patients

por Lu, Baohua, Zhang, Hongmei, Zhang, Tongmei, Cai, Yiran, Hu, Ying, Zheng, Hua, Li, Baolan
Publicado 2016

A single center analysis of first-line treatment in advanced KRAS mutant non-small cell lung cancer: real-world practice

por Liu, Yanxia, Gao, Yuan, Wang, Ying, Zhao, Cong, Zhang, Zhiyun, Li, Baolan, Zhang, Tongmei
Publicado 2022

Beneficial effects of postoperative radiotherapy for IIIA‑N2 non‑small cell lung cancer after radical resection analysed using the propensity score‑matching method

por Tian, Cuimeng, Liu, Guimei, Xu, Yongxiang, Xia, Guangrong, Zhang, Tongmei, Huang, Jiaqiang, Liu, Fangchao, Li, Baolan
Publicado 2023

Downregulation of Cyclophilin A by siRNA diminishes non-small cell lung cancer cell growth and metastasis via the regulation of matrix metallopeptidase 9

por Qian, Zhe, Zhao, Xiaoting, Jiang, Mei, Jia, Wenyun, Zhang, Chunyan, Wang, Yue, Li, Baolan, Yue, Wentao
Publicado 2012

Association between VEGFR-3 expression and lymph node metastasis in non-small-cell lung cancer

por LI, JIE, YI, HAN, LIU, ZHIDONG, ZHANG, HAIQING, ZHANG, DEZONG, YUE, WENTAO, JIA, HONGYAN, XU, SHAOFA, LI, BAOLAN
Publicado 2015

Vimentin expression in circulating tumor cells (CTCs) associated with liver metastases predicts poor progression-free survival in patients with advanced lung cancer

por Wang, Ying, Liu, Yanxia, Zhang, Lina, Tong, Li, Gao, Yuan, Hu, Fanbin, Lin, Peter Ping, Li, Baolan, Zhang, Tongmei
Publicado 2019

Postoperative Radiotherapy for Patients with Completely Resected Pathological Stage IIIA-N2 Non-small Cell Lung Cancer: A Preferential Benefit for Squamous Cell Carcinoma

por Tian, Cuimeng, Liu, Guimei, Xu, Yongxiang, Xia, Guangrong, Zhang, Tongmei, Huang, Jiaqiang, Jiang, Hui, Ming Wang, Ji, Li, Baolan
Publicado 2020

Comprehensive Comparative Molecular Characterization of Young and Old Lung Cancer Patients

por Hu, Mingming, Tan, Jinjing, Liu, Zhentian, Li, Lifeng, Zhang, Hongmei, Zhao, Dan, Li, Baolan, Gao, Xuan, Che, Nanying, Zhang, Tongmei
Publicado 2022

Hyaluronic Acid Correlates With Bone Metastasis and Predicts Poor Prognosis in Small-Cell Lung Cancer Patients

por Zhao, Cong, Zhang, Zhiyun, Hu, Xingsheng, Zhang, Lina, Liu, Yanxia, Wang, Ying, Guo, Yi, Zhang, Tongmei, Li, Weiying, Li, Baolan
Publicado 2022

Post-therapeutic circulating tumor cell-associated white blood cell clusters predict poor survival in patients with advanced driver gene-negative non-small cell lung cancer

por Wang, Ying, Liu, Yanxia, Zhang, Zhiyun, Lu, Baohua, Gao, Yuan, Tong, Li, Hu, Mingming, Lin, Peter Ping, Li, Baolan, Zhang, Tongmei
Publicado 2023

Plasma hepatocyte growth factor as a noninvasive biomarker in small cell lung cancer

por Zhao, Cong, Tong, Li, Liu, Bin, Qi, Fei, Zhang, Zhiyun, Guo, Yi, Liu, Yanxia, Wang, Ying, Zhang, Lina, Lu, Baohua, Li, Baolan, Zhang, Tongmei
Publicado 2023

Investigating the mechanism by which SMAD3 induces PAX6 transcription to promote the development of non-small cell lung cancer

por Qian, Zhe, Zhang, Qiankun, Hu, Ying, Zhang, Tongmei, Li, Jie, Liu, Zan, Zheng, Hua, Gao, Yuan, Jia, Wenyun, Hu, Aimin, Li, Baolan, Hao, Jiqing
Publicado 2018

Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: a multicentre, randomised phase II trial (ALTER0302)

por Han, Baohui, Li, Kai, Zhao, Yizhuo, Li, Baolan, Cheng, Ying, Zhou, Jianying, Lu, You, Shi, Yuankai, Wang, Zhehai, Jiang, Liyan, Luo, Yi, Zhang, Yiping, Huang, Cheng, Li, Qiang, Wu, Guoming
Publicado 2018

Role of aneuploid circulating tumor cells and CD31(+) circulating tumor endothelial cells in predicting and monitoring anti‐angiogenic therapy efficacy in advanced NSCLC

por Zhang, Tongmei, Zhang, Lina, Gao, Yuan, Wang, Ying, Liu, Yanxia, Zhang, Hongmei, Wang, Qunhui, Hu, Fanbin, Li, Jie, Tan, Jinjing, Wang, Daisy Dandan, Gires, Olivier, Lin, Peter Ping, Li, Baolan
Publicado 2021

Effect of anlotinib as a third‐ or further‐line therapy in advanced non‐small cell lung cancer patients with different histologic types: Subgroup analysis in the ALTER0303 trial...

por Cheng, Ying, Han, Baohui, Li, Kai, Wang, Qiming, Zhang, Li, Shi, Jianhua, Wang, Zhehai, He, Jianxing, Shi, Yuankai, Chen, Weiqiang, Wang, Xiuwen, Luo, Yi, Nan, Kejun, Jin, Faguang, Li, Baolan, Zhu, Jing
Publicado 2020